首页> 外文期刊>BMJ Open Quality >Report into "on the day cancellations" for plastic surgery in patients who failed to stop their medication
【24h】

Report into "on the day cancellations" for plastic surgery in patients who failed to stop their medication

机译:向未能停药的患者进行整日“每日取消”报告

获取原文
       

摘要

Abstract It was noted that a number of patients were having their procedures cancelled on the day of surgery because their antiplatelet or anticoagulative medications had not been stopped preoperatively. The team recognised that this problem was leading to an unnecessary waste of the department‘s labour and financial resources, and more importantly was becoming a source of disappointment and anxiety to patients.A retrospective analysis of all plastic surgery cases was performed for procedures listed for the previous 12 months. All cancellations and the reasons for them were recorded, which came to 23 cases. The sum of the financial tariffs for each cancelled procedure was calculated to assess the financial impact of the identified problem: £20,000. A root cause analysis was performed to assess where this problem was arising in the patient’s preoperative journey. The common theme was the lack of information for the gatekeeper regarding the patients9 anticoagulant and antiplatelet medications.A new gatekeeper form was introduced to practice with a subsection specifically highlighting antiplatelet and anticoagulative medications. In addition, this issue was highlighted to the relevant staff in the department.After four months, a second PDSA cycle was performed in the same manner. Seven cases were cancelled due to anticoagulants or antiplatelets not being stopped prior to surgery. This equated to a net loss of £11,865 to the department when projected over 12 months, improving on the performance prior to the newly introduced changes.
机译:摘要注意到许多患者在手术当天就取消了手术,因为他们的抗血小板或抗凝药物并未在术前停止。研究小组认识到这个问题导致不必要地浪费了部门的人力和财力,更重要的是正成为患者失望和焦虑的根源。前12个月。记录了所有取消情况及其原因,共计23起。计算每个被取消程序的财务关税总和,以评估所发现问题的财务影响:£ 20,000。进行了根本原因分析,以评估该问题在患者术前旅程中出现的位置。共同的主题是看门人缺乏有关患者9抗凝和抗血小板药物的信息。一种新的看门人表格被引入实践,其中一个小节专门介绍了抗血小板和抗凝药物。此外,向部门的相关人员强调了这个问题。四个月后,以相同的方式执行了第二个PDSA周期。由于抗凝剂或抗血小板剂在手术前没有停止,因此取消了7例病例。预计在12个月内该部门将净损失11,865英镑,这将改善新引入的变更之前的绩效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号